Similarly, miR-100 has a negative impact on prostate cancer cells by down-regulating the oncogene argonaute 2 (AGO2), which can mediate stemness factors of cancer cells such as OCT4, Krüppel-like factor 4 (KLF4), and c-myc. Here, KLF4 is linked to prostate cancer.